Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 13Glioblastoma 6Glioma 5Epilepsy 5Stroke 3Pheochromocytoma 3Parkinson Disease 3Paraganglioma 3Neuroblastoma 3Neoplasms 3Speech 2Neurofibromatosis 1 2Neurofibroma 2Multiple Sclerosis 2Migraine Disorders 2Lung Neoplasms 2Diabetes Mellitus 2Carcinoma, Non-Small-Cell Lung 2Amyotrophic Lateral Sclerosis 2Adrenal Gland Neoplasms 2Tinnitus 1Thyroid Neoplasms 1Tension-Type Headache 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Spinal Stenosis 1Spinal Cord Injuries 1Skin Neoplasms 1Restless Legs Syndrome 1Renal Insufficiency, Chronic 1

Interventions

fluorodopa F 18 1Magnetic Resonance Spectroscopy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Parkinsonian Disorders × CNS × Clear all
NCT07542158 2026-04-21

Ultralow Dose PET Imaging of 18F-FDOPA

Nuclear Imaging Institute

Phase 2 Enrolling by invitation
200 enrolled
CNS

Glioma, Neoplasms, Parkinsonian Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡